InvestorsHub Logo
icon url

Toddrobertking

05/05/20 8:18 AM

#271341 RE: rafunrafun #271340

"potential generic entrants will not be able to procure sufficient quantities of FDA-grade icosapent ethyl to pose a material commercial threat"
icon url

biowreck

05/05/20 9:10 AM

#271350 RE: rafunrafun #271340

According to TipRanks.com, Byrnes ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -19.7% and a 24.3% success rate. Byrnes covers the Healthcare sector,